Radiogenomics to characterize the immune-related prognostic signature associated with biological functions in glioblastoma.
Eur Radiol
; 33(1): 209-220, 2023 Jan.
Article
em En
| MEDLINE
| ID: mdl-35881182
ABSTRACT
OBJECTIVES:
The tumor microenvironment and immune cell infiltration (ICI) associated with glioblastoma (GBM) play a vital role in cancer development, progression, and prognosis. This study aimed to establish an ICI-related prognostic biomarker and explore the associations between ICI signatures and radiomic features in patients with GBM.METHODS:
The gene expression and survival data of patients with GBM were obtained from three databases. Based on the ICI pattern, an individualized ICI score for each GBM patient was developed in the discovery set (n = 400) and independently verified in the validation set (n = 374). A total of 5915 radiomic features were extracted from the intratumoral and peritumoral regions. Recursive feature elimination and support vector machine methods were performed to select the key features and generate a model predictive of low- or high- ICI scores. The prognostic value of the identified radio genomic model was examined in an independent dataset (n = 149) using imaging and survival data.RESULTS:
We found that higher ICI scores often indicated worse patient prognosis (multivariable hazard ratio 0.48 and 0.63 in discovery and validation set, respectively) and higher expression levels of immune checkpoint-related genes. A model that combined 11 radiomic features could well distinguish tumors with different ICI scores (AUC = 0.96, accuracy = 94%). This model was proven to be helpful for noninvasive prognostic stratification in an independent validation cohort.CONCLUSIONS:
ICI scores may serve as an effective prognostic biomarker to characterize potential biological processes in patients with GBM. This ICI signature can be evaluated noninvasively through radiogenomic analysis. KEY POINTS ⢠Immune cell infiltration (ICI) scores can serve as an effective prognostic biomarker in patients with glioblastoma. ⢠The ICI signature can be evaluated noninvasively through radiomic features derived from the intratumoral and peritumoral regions. ⢠The prognostic value of the radiogenomic model can be verified by independent survival and MRI data.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Fenômenos Biológicos
/
Neoplasias Encefálicas
/
Glioblastoma
Tipo de estudo:
Prognostic_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
En
Revista:
Eur Radiol
Assunto da revista:
RADIOLOGIA
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
China